Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
In this study, investigators will evaluate the efficacy and related mechanism of probiotics
and prebiotics as an add-on treatment in improving the antipsychotic induced psychotic
syndrome, the cognitive impairment, gastrointestinal function, and metabolic disorders in
schizophrenia patients, through genotype identification, psychopathology, neuropsychology,
biochemical evaluation and other methods.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Collaborators:
BaoJi Rehabilitation Hospital HanZhong Psychiatric Hospital WeiNan Psychiatry Hospital Xiangyang Central Hospital Xianyang Central Hospital